Not registered yet?
Registration is free, quick and easy. You'll get more access to our content and extra features such as commenting and personalised newsletters.Register now
Settlement also resolves disputes with shareholders
Areas around manufacturing sites still heavily contaminated with antimicrobials and breeding multidrug-resistant pathogens
$7.2bn deal expands Thermo Fisher’s laboratory products and services segment